Literature DB >> 4338591

Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex.

H B Brewer, S E Lux, R Ronan, K M John.   

Abstract

An apolipoprotein, designated by its carboxyl-terminal residue as apoLp-Gln-II, has been isolated from the human high-density lipoprotein family, and its complete aminoacid sequence was determined. The apoprotein, one of the two major apoproteins of this family, is composed of two identical polypeptide chains, each containing 77 amino acids. The two polypeptide chains are connected by a single disulfide bridge at position 6 in the sequence. The minimum molecular weight of the intact apoprotein is 17,380. The amino-terminal residue of each chain is pyrrolidone carboxylic acid, and the carboxyl-terminal residue is glutamine.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4338591      PMCID: PMC426687          DOI: 10.1073/pnas.69.5.1304

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  23 in total

1.  Analysis of amino acid phenylthiohydantoins by gas chromatography.

Authors:  J J Pisano; T J Bronzert
Journal:  J Biol Chem       Date:  1969-10-25       Impact factor: 5.157

2.  Heterogeneity in protein subunits of human serum high-density lipoproteins.

Authors:  B Shore; V Shore
Journal:  Biochemistry       Date:  1968-08       Impact factor: 3.162

3.  The effect of reduction and carboxymethylation on the circular dichroic spectra of two polypeptide classes of serum high density lipoprotein.

Authors:  A M Scanu
Journal:  Biochim Biophys Acta       Date:  1970-03-31

4.  The amino acid sequence of bovine parathyroid hormone I.

Authors:  H D Niall; H Keutmann; R Sauer; M Hogan; B Dawson; G Aurbach; J Potts
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-12

5.  [Complete and automatic degradation of peptides acording to the quadrol method].

Authors:  G Braunitzer; B Schrank; A Ruhfus
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1970-12

6.  Changes in human serum high-density lipoproteins induced by disulfide-exchange reagents.

Authors:  L Cohen; J Djordjevich
Journal:  Proc Soc Exp Biol Med       Date:  1968-12

7.  Conformation of human serum high density lipoprotein and its peptide components.

Authors:  A M Gotto; B Shore
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

8.  Fractionation of human serum high density lipoprotein in urea solutions. Evidence for polypeptide heterogeneity.

Authors:  A Scanu; J Toth; C Edelstein; S Koga; E Stiller
Journal:  Biochemistry       Date:  1969-08       Impact factor: 3.162

9.  Forms of human serum high density lipoprotein protein.

Authors:  A Scanu
Journal:  J Lipid Res       Date:  1966-03       Impact factor: 5.922

10.  Electrophoretic heterogeneity of polypeptide chains of specific antibodies.

Authors:  R A Reisfeld; P A Small
Journal:  Science       Date:  1966-05-27       Impact factor: 47.728

View more
  42 in total

1.  The composition and metabolism of high density lipoprotein subfractions.

Authors:  E J Schaefer; D M Foster; L L Jenkins; F T Lindgren; M Berman; R I Levy; H B Brewer
Journal:  Lipids       Date:  1979-05       Impact factor: 1.880

Review 2.  The mechanism of lipid-binding by plasma lipoproteins.

Authors:  R L Jackson; J D Morrisett; A M Gotto; J P Segrest
Journal:  Mol Cell Biochem       Date:  1975-01-31       Impact factor: 3.396

3.  Lipid-F1 nucleohistone interactions.

Authors:  F A Manzoli; J H Muchmore; S Capitani; B Bonora; S Bartoli
Journal:  Mol Cell Biochem       Date:  1976-02-25       Impact factor: 3.396

Review 4.  HDL metabolism and the role of HDL in the treatment of high-risk patients with cardiovascular disease.

Authors:  H Bryan Brewer
Journal:  Curr Cardiol Rep       Date:  2007-11       Impact factor: 2.931

5.  The role of apoproteins AI and AII in binding of high-density lipoprotein3 to membranes derived from bovine aortic endothelial cells.

Authors:  P K Vadiveloo; N H Fidge
Journal:  Biochem J       Date:  1992-05-15       Impact factor: 3.857

6.  Phylogenies constrained by the crossover process as illustrated by human hemoglobins and a thirteen-cycle, eleven-amino-acid repeat in human apolipoprotein A-I.

Authors:  W M Fitch
Journal:  Genetics       Date:  1977-07       Impact factor: 4.562

7.  Isolation and characterization of a human serum cholesteryl ester transfer protein.

Authors:  T Chajek; C J Fielding
Journal:  Proc Natl Acad Sci U S A       Date:  1978-07       Impact factor: 11.205

8.  Studies on the protein defect in Tangier disease. Isolation and characterization of an abnormal high density lipoprotein.

Authors:  S E Lux; R I Levy; A M Gotto; D S Fredrickson
Journal:  J Clin Invest       Date:  1972-10       Impact factor: 14.808

9.  Posttranslational modifications of apolipoprotein A-II proteoforms in type 2 diabetes.

Authors:  Ida Azizkhanian; Olgica Trenchevska; Yara Bashawri; Jiaqi Hu; Juraj Koska; Peter D Reaven; Randall W Nelson; Dobrin Nedelkov; Hussein N Yassine
Journal:  J Clin Lipidol       Date:  2016-03-08       Impact factor: 4.766

10.  Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance.

Authors:  C R Sharpe; A Sidoli; C S Shelley; M A Lucero; C C Shoulders; F E Baralle
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.